These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7502848)

  • 1. Effect of cholera toxin and its B subunit on intestinal permeability for ovalbumin.
    Pierre PG; Mbella EG; Vaerman JP
    Adv Exp Med Biol; 1995; 371B():1519-21. PubMed ID: 7502848
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholera toxin-mediated cellular immune responses against ovalbumin administered orally.
    Bowen JC; Reddy RM; Rouse BT
    Adv Exp Med Biol; 1995; 371B():1531-3. PubMed ID: 7502851
    [No Abstract]   [Full Text] [Related]  

  • 3. Mucosal suppression by oral pre-treatment with ovalbumin and its conversion into stimulation when ovalbumin was conjugated to cholera toxin or its B subunit.
    van der Heijden PJ; Stok W; Bianchi AT
    Adv Exp Med Biol; 1995; 371B():1251-5. PubMed ID: 7502794
    [No Abstract]   [Full Text] [Related]  

  • 4. Modulating dendritic cells to optimize mucosal immunization protocols.
    Williamson E; Westrich GM; Viney JL
    J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of natural and recombinant cholera toxin B subunit as stimulatory factors in intranasal immunization.
    de Geus B; Dol-Bosman M; Scholten JW; Stok W; Bianchi A
    Vaccine; 1997 Jul; 15(10):1110-3. PubMed ID: 9269054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
    Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
    Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of ovalbumin-specific IgA responses via oral boosting with antigen co-administered with an aqueous Solanum torvum extract.
    Israf DA; Lajis NH; Somchit MN; Sulaiman MR
    Life Sci; 2004 Jun; 75(4):397-406. PubMed ID: 15147827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholera toxin as a mucosal adjuvant: III. Antibody responses to nontarget dietary antigens are not increased.
    Nedrud JG; Sigmund N
    Reg Immunol; 1990-1991; 3(5):217-22. PubMed ID: 1966580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral tolerance to ovalbumin in mice: effect of some parameters on the induction and persistence of the suppression of systemic IgE and IgG antibody responses.
    Moreau MC; Coste M; Gaboriau V; Dubuquoy C
    Adv Exp Med Biol; 1995; 371B():1229-34. PubMed ID: 7502789
    [No Abstract]   [Full Text] [Related]  

  • 10. Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice.
    Van der Heijden PJ; Bianchi AT; Dol M; Pals JW; Stok W; Bokhout BA
    Immunology; 1991 Jan; 72(1):89-93. PubMed ID: 1705237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD11c(high )dendritic cells are essential for activation of CD4+ T cells and generation of specific antibodies following mucosal immunization.
    Fahlén-Yrlid L; Gustafsson T; Westlund J; Holmberg A; Strömbeck A; Blomquist M; MacPherson GG; Holmgren J; Yrlid U
    J Immunol; 2009 Oct; 183(8):5032-41. PubMed ID: 19786541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo.
    Porgador A; Staats HF; Faiola B; Gilboa E; Palker TJ
    J Immunol; 1997 Jan; 158(2):834-41. PubMed ID: 8993001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of freeze-dried kefir reduces intestinal permeation of and oral sensitization to ovalbumin in mice.
    Umeda C; Sonoyama K; Yamaguchi N; Saito R; Akashi K; Motoshima H; Kawabata J
    Biosci Biotechnol Biochem; 2005 Jan; 69(1):249-51. PubMed ID: 15665499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of antigen-specific long-term memory cells in systemic lymphoid tissues as well as locally in the gut lamina propria following oral immunization with cholera toxin adjuvant.
    Vajdy M; Lycke N
    Adv Exp Med Biol; 1995; 371B():1495-500. PubMed ID: 7502844
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of neonatal sublingual vaccination with native or denatured ovalbumin and adjuvant CpG or cholera toxin on systemic and mucosal immunity in mice.
    Huang CF; Wu TC; Chu YH; Hwang KS; Wang CC; Peng HJ
    Scand J Immunol; 2008 Nov; 68(5):502-10. PubMed ID: 18822109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholera and pertussis toxins, but not forskolin or LT-B, adjuvant IgA antibody responses to orally administered antigen.
    Wilson AD; Robinson A; Irons L; Stokes CR; Bland PW
    Adv Exp Med Biol; 1995; 371B():1523-6. PubMed ID: 7502849
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of oral tolerance to ovalbumin by cholera toxin and its B subunit.
    Pierre P; Denis O; Bazin H; Mbongolo Mbella E; Vaerman JP
    Eur J Immunol; 1992 Dec; 22(12):3179-82. PubMed ID: 1446708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant action of Chenopodium quinoa saponins on the induction of antibody responses to intragastric and intranasal administered antigens in mice.
    Estrada A; Li B; Laarveld B
    Comp Immunol Microbiol Infect Dis; 1998 Jul; 21(3):225-36. PubMed ID: 9681245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens.
    Bowen JC; Nair SK; Reddy R; Rouse BT
    Immunology; 1994 Mar; 81(3):338-42. PubMed ID: 8206507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live varicella vaccine polarizes the mucosal adjuvant action of cholera toxin or its B subunit on specific Th1-type helper T cells with a single nasal coadministration in mice.
    Sasaki K; Kato M; Takahashi T; Ochi S; Ichinose Y; Shiraki K; Asano Y; Iwanaga M; Tsuji T
    J Med Virol; 2003 Jun; 70(2):329-35. PubMed ID: 12696126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.